102 results on '"Chow, Edward Kai‐Hua"'
Search Results
2. Abstract P43: Optimization of DNA Methyltransferase Inhibitors-based Combination to Target the Epigenome of Gastric Cancer
3. Pushing the Frontiers of Cancer Research: Highlights from the Frontiers in Cancer Science Conference 2023
4. A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
5. Pazopanib elicits remarkable response in metastatic porocarcinoma: a functional precision medicine approach
6. Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
7. Nanodiamonds and Their Applications in Drug Delivery and Bioimaging
8. Biomedical applications of nanodiamonds: From drug-delivery to diagnostics
9. Functional Personalized Treatment of Metastatic Porocarcinoma
10. NanoBeacon.AI: AI-Enhanced Nanodiamond Biosensor for Automated Sensitivity Prediction to Oxidative Phosphorylation Inhibitors
11. In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal Carcinoma
12. Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
13. The 2023 SLAS Technology ten: Translating life sciences innovation
14. Abstract B023: Personalized phenotypic ex vivo drug sensitivity platform identifies frequent HDAC inhibitor-based combination sensitivities in T-cell lymphomas
15. WisDM Green: Harnessing Artificial Intelligence to Design and Prioritize Compound Combinations in Peat Moss for Sustainable Farming Applications
16. Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
17. Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC ‐driven hepatocellular carcinoma
18. Cancer Stem Cell Drug Delivery
19. IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention
20. Ex vivo drug testing in an ultra-rare sarcoma reveals therapeutic vulnerability and resistance
21. The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
22. WisDM Green: Harnessing Artificial Intelligence to Design and Prioritize Compound Combinations in Peat Moss for Sustainable Farming Applications
23. WisDM Green: Harnessing Artificial Intelligence to Design and Prioritize Compound Combinations in Peat Moss for Sustainable Farming Applications
24. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment
25. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
26. The 2022 SLAS technology ten: Translating life sciences innovation
27. Addressing antimicrobial resistance with the IDentif.AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria
28. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer
29. Safety evaluation of nanodiamond-doxorubicin complexes in a Naïve Beagle canine model using hematologic, histological, and urine analysis
30. A chemical biology approach reveals a dependency of glioblastoma on biotin distribution
31. The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy Regimens
32. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery
33. Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age
34. The 2020 SLAS Technology Top Ten: Translating Life Sciences Innovation
35. Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models
36. IDentif . AI : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development
37. Advances in Technology to Address COVID-19
38. Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma
39. Abstract CT268: CURATE.AI-optimized modulation for multiple myeloma: An N-of-1 randomized trial
40. Abstract 3929: Patient-derived pancreatic cancer organoids as in-vitro cancer models for personalizing therapy
41. Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression
42. Photodynamic Therapy: A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy (Adv. Mater. 29/2020)
43. A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy
44. Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
45. IDentif.AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
46. The 2020 SLAS Technology Ten: Translating Life Sciences Innovation
47. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
48. Abstract B140: AI-driven drug combination design for drug-resistant hematological malignancies
49. Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy
50. Maximizing Efficiency of Artificial Intelligence‐Driven Drug Combination Optimization through Minimal Resolution Experimental Design
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.